EBITDA: Income before interest, taxes, depreciation and amortization.
Integrated BioPharma Inc. (INBP) had EBITDA of $-0.49M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$9.80M |
|
$-1.37M |
|
$9.77M |
|
$0.03M |
|
$10.66M |
|
$-0.87M |
|
$0.02M |
|
$-0.85M |
|
$-0.85M |
|
$-1.37M |
|
$-1.37M |
|
$-1.37M |
|
$-1.37M |
|
$-0.87M |
|
|
EBITDA |
$-0.49M |
31.06M |
|
31.06M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$17.38M |
|
$1.75M |
|
$7.96M |
|
$25.34M |
|
$5.80M |
|
$0.07M |
|
$1.87M |
|
$7.67M |
|
$17.67M |
|
$17.67M |
|
$17.67M |
|
31.09M |
|
| Cash Flow Statement Financials | |
$1.24M |
|
$-0.34M |
|
$-0.04M |
|
$3.62M |
|
$4.47M |
|
$0.86M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.00 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
0.29% |
|
-8.87% |
|
-8.87% |
|
-- |
|
-8.68% |
|
-13.94% |
|
$0.90M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
1.07 |
|
2.94 |
|
30.63 |
|
-7.73% |
|
-7.73% |
|
-5.39% |
|
-7.70% |
|
$0.57 |
|
$0.03 |
|
$0.04 |
|